NCT04007276View on ClinicalTrials.gov

The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

November 10, 2026

Primary Completion Date

June 1, 2031

Study Completion Date

June 1, 2036

Conditions
GlaucomaGlaucoma, Open-AngleGlaucoma; DrugsDroopy EyelidPtosisGlaucoma, Primary Open Angle
Interventions
DRUG

brimonidine tartrate ophthalmic solution 0.025%

Single dose of brimonidine tartrate ophthalmic solution 0.025% applied as an eye drop to the eye surface.

OTHER

sterile balanced saline solution

Single dose of sterile balanced saline solution applied as an eye drop to the eye surface.

Trial Locations (1)

70112

Tulane University Medical Center, New Orleans

All Listed Sponsors
lead

Tulane University

OTHER